Sponsor:
Barbara Ann Karmanos Cancer Institute
Code:
NCT06908629
Conditions
Cancer
Cancer Survivors
Gastrointestinal Cancers
Neuroendocrine Tumors
Multiple Myeloma, Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Implementation of social determinants of health screening and referral
Brief summary:
Conditions
Cancer
Cancer Survivors
Gastrointestinal Cancers
Neuroendocrine Tumors
Multiple Myeloma, Neoplasms
Study ID
NCT06908629
Start date
Sep 3, 2024
Status verified date
Aug, 2025
Completion date
May, 2027
Anticipated
Primary completion date
May, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Intervention Model
Single group
Primary purpose
Screening
Arms
experimental: Screening Needs Assessment
Interventions
Implementation of social determinants of health screening and referral
Primary outcome measure
Central contacts
Locations
Karmanos Cancer Institute
Recruiting
Detroit, Michigan, United States, 48201
Contacts
Hayley S. Thompson, PhD
313-576-9734Sponsor
Barbara Ann Karmanos Cancer Institute
Last update posted
Aug 26, 2025
Last verified
Aug, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Barbara Ann Karmanos Cancer Institute on 2025-08-26.